Reportlinker Adds North America In Vitro Diagnostics Market Outlook to 2016
NEW YORK, Dec. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
North America In Vitro Diagnostics Market Outlook to 2016
http://www.reportlinker.com/p0336539/North-America-In-Vitro-Diagnostics-Market-Outlook-to-2016.html
North America In Vitro Diagnostics Market Outlook to 2016
Summary
GlobalData's new report, "North America In Vitro Diagnostics Market Outlook to 2016" provides key market data on the North America In Vitro Diagnostics market – United States and Canada. The report provides value (USD million) data for all the market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Genetic Testing and Histology And Cytology. The report also provides company shares and distribution shares data for each of the before mentioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts
Scope
- Countries covered include United States and Canada.
- Market size and company share data for Diagnostic Imaging market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Genetic Testing and Histology And Cytology.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the North America In Vitro Diagnostics market.
- Key players covered include Siemens Healthcare., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc Ortho-Clinical Diagnostics Inc, Alere Inc, Becton, Dickinson and Company, Biomerieux Sa, Qiagen N.V, Bio-Rad Laboratories, Inc , Gen-Probe Incorporated , Hologic, Inc and Sysmex Corporation.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the North America In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 12
2.1 What is This Report About? 12
3 In Vitro Diagnostics in North America 13
3.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($m), 2002-2016 13
3.2 In Vitro Diagnostics, North America, Overall Revenue ($m), 2002-2016 14
3.3 In Vitro Diagnostics, North America, Company share (2008-2009) 21
4 In Vitro Diagnostics In United States 23
4.1 In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 23
4.2 In Vitro Diagnostics, United States, Distribution Share (2008-2009) 29
4.2.1 Clinical Chemistry, United States, Distribution Share (2008-2009) 29
4.2.2 Genetic Testing, United States, Distribution Share (2008-2009) 29
4.2.3 Haematology, United States, Distribution Share (2008-2009) 30
4.2.4 Histology and Cytology, United States, Distribution Share (2008-2009) 30
4.2.5 Immuno Chemistry, United States, Distribution Share (2008-2009) 31
4.2.6 Infectious Immunology, United States, Distribution Share (2008-2009) 31
4.2.7 Microbiology Culture, United States, Distribution Share (2008-2009) 32
4.3 In Vitro Diagnostics, United States, Company Share (2008-2009) 33
4.3.1 In Vitro Diagnostics, United States, Company Share (2008-2009) 33
4.3.2 Clinical Chemistry, United States, Company Share (2008-2009) 35
4.3.3 Genetic Testing, United States, Company Share (2008-2009) 37
4.3.4 Haematology, United States, Company Share (2008-2009) 39
4.3.5 Histology And Cytology, United States, Company Share (2008-2009) 41
4.3.6 Immuno Chemistry, United States, Company Share (2008-2009) 43
4.3.7 Infectious Immunology, United States, Company Share (2008-2009) 45
4.3.8 Microbiology Culture, United States, Company Share (2008-2009) 47
5 In Vitro Diagnostics In Canada 49
5.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016 49
5.2 In Vitro Diagnostics, Canada, Distribution Share (2008-2009) 55
5.2.1 Clinical Chemistry, Canada, Distribution Share (2008-2009) 55
5.2.2 Genetic Testing, Canada, Distribution Share (2008-2009) 55
5.2.3 Haematology, Canada, Distribution Share (2008-2009) 56
5.2.4 Histology and Cytology, Canada, Distribution Share (2008-2009) 56
5.2.5 Immuno Chemistry, Canada, Distribution Share (2008-2009) 57
5.2.6 Infectious Immunology, Canada, Distribution Share (2008-2009) 57
5.2.7 Microbiology Culture, Canada, Distribution Share (2008-2009) 58
5.3 In Vitro Diagnostics, Canada, Company Share (2008-2009) 59
5.3.1 In Vitro Diagnostics, Canada, Company Share (2008-2009) 59
5.3.2 Clinical Chemistry, Canada, Company Share (2008-2009) 61
5.3.3 Genetic Testing, Canada, Company Share (2008-2009) 63
5.3.4 Haematology, Canada, Company Share (2008-2009) 65
5.3.5 Histology and Cytology, Canada, Company Share (2008-2009) 66
5.3.6 Immuno Chemistry, Canada, Company Share (2008-2009) 68
5.3.7 Infectious Immunology, Canada, Company Share (2008-2009) 70
5.3.8 Microbiology Culture, Canada, Company Share (2008-2009) 72
6 Overview of Key Companies in North America In Vitro Diagnostics Market 73
6.1 Siemens Healthcare 73
6.1.1 Company Overview 73
6.1.2 Share in the North America In Vitro Diagnostics Market 73
6.2 Abbott Laboratories 74
6.2.1 Company Overview 74
6.2.2 Share in the North America In Vitro Diagnostics Market 74
6.3 F. Hoffmann-La Roche Ltd. 75
6.3.1 Company Overview 75
6.3.2 Share in the North America In Vitro Diagnostics Market 75
6.4 Beckman Coulter, Inc. 76
6.4.1 Company Overview 76
6.4.2 Share in the North America In Vitro Diagnostics Market 76
6.5 Ortho-Clinical Diagnostics Inc. 77
6.5.1 Company Overview 77
6.5.2 Share in the North America In Vitro Diagnostics Market 77
6.6 Alere Inc 78
6.6.1 Company Overview 78
6.6.2 Share in the North America In Vitro Diagnostics Market 78
6.7 Becton, Dickinson and Company 79
6.7.1 Company Overview 79
6.8 bioMerieux S.A. 79
6.8.1 Company Overview 79
6.9 Qiagen N.V. 80
6.9.1 Company Overview 80
6.10 Bio-Rad Laboratories, Inc. 80
6.10.1 Company Overview 80
6.11 Gen-Probe Incorporated 80
6.11.1 Company Overview 80
6.12 Hologic, Inc. 81
6.12.1 Company Overview 81
6.13 Sysmex Corporation 81
6.13.1 Company Overview 81
6.14 Phadia AB 82
6.14.1 Company Overview 82
7 Financial Deals Landscape 83
7.1 Merger 83
7.1.1 Renato to Merge With Pharmaceutical Group and Medical Clinics 83
7.1.2 Genelex Merges With Mental Health Connections 84
7.1.3 ChromoCure Merges With Genome Research Group 85
7.2 Acquisition 86
7.2.1 Geonostics Acquires FlexSite Diagnostics 86
7.2.2 ITT Completes The Acquisition Of O.I. 87
7.2.3 Med BioGene Announces The Sale Of The Company 88
7.2.4 GE Healthcare Receives US Antitrust Approval To Acquire Clarient 89
7.2.5 Pole Perfect Studios To Acquire LumiGene Technologies In Reverse Acquisition 91
7.2.6 ERBA DIAGNOSTICS MANNHEIM Completes Acquisition Of 72% Stake In IVAX Diagnostics From Patrice Debregeas and Paul Kennedy 92
7.2.7 NEC Invests $5 Million In SomaLogic 93
7.2.8 Ventana Medical Systems To Acquire BioImagene 94
7.3 Partnerships 95
7.3.1 Vermillion Enters Into An Agreement With Quest Diagnostics 95
7.3.2 Radient Pharmaceuticals Enters Into An Agreement With Provista Diagnostics 96
7.3.3 Cepheid Enters Into Collaboration With Novartis 97
7.3.4 T-Ray Science Enters Into Research Agreement With The BC Cancer Agency 98
7.3.5 BD Diagnostic Enters Into An Agreement With Bruker Daltonics 99
7.3.6 ECI Biotech Enters Into An Agreement With Systagenix Wound Management 100
7.3.7 Celera Enters Into Distribution Agreement With Abbott Laboratories 101
7.3.8 Prometheus Laboratories Enters Into Research Collaboration And License Agreement With Tarrot Laboratories 102
7.3.9 Biomoda Signs Research Agreement With Saccomanno Research Institute 103
8 Recent Developments 104
8.1 Strategy and Business Planning 104
8.1.1 Nov 08, 2010: Abbott Joins Forces With CHAI 104
8.1.2 Nov 08, 2010: Agilent Technologies And Wyss Institute Announce Collaboration To Advance Burgeoning Discipline of Biologically Inspired Engineering 104
8.1.3 Oct 27, 2010: IntegraGen To Open US Subsidiary In Cambridge, Massachusetts 105
8.1.4 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 105
8.1.5 Oct 14, 2010: NinePoint Medical Establishes Corporate Headquarters In Massachusetts 106
8.1.6 Oct 12, 2010: Tecan, Luminex Partner To Develop Automated Newborn Screening Solution 107
8.1.7 Oct 12, 2010: Sirius Genomics, Golden Helix Collaborate On Companion Diagnostic Development 107
8.1.8 Sep 13, 2010: Response Biomedical Announces Strategic Realignment Of Resources 108
8.1.9 Aug 26, 2010: New York State Licenses Genelex's DNA Drug Sensitivity Tests 108
8.1.10 Aug 19, 2010: Amerinet Partners With St. Barnabas-Bronx And OraSure Technologies To Implement Efficient HIV Testing Procedures 109
8.1.11 Aug 18, 2010: T-Ray Announces Reorganization 109
8.1.12 Aug 13, 2010: Thermo Fisher To Shut Down Rhode Island Facility By June 2011 110
8.1.13 Aug 12, 2010: Clearstone Central Laboratories And LabCorp Form Strategic Collaboration For Clinical Trials 110
8.1.14 Aug 09, 2010: NoAb BioDiscoveries And VigiCell Sign Collaboration And Co-Distribution Agreement In Principle 110
8.2 Legal and Regulatory 111
8.2.1 Nov 10, 2010: Affymetrix Files Lawsuit Against PacBio For Poaching Staff 111
8.2.2 Nov 08, 2010: US Department Of Justice Closes Its Investigation Of Immucor 111
8.2.3 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions 111
8.2.4 Oct 25, 2010: Helicos Amends Patent Infringement Lawsuit Against PacBio To Include Illumina And Life Technologies 112
8.2.5 Oct 22, 2010: Ryan & Maniskas Investigates Possible Breach Of Fiduciary Duty By Board Of Clarient 112
8.2.6 Oct 22, 2010: Streck Patents Valid, Infringed By R&D Systems District Court Issues Permanent Injunction 113
8.2.7 Sep 21, 2010: Robbins Geller Files Class Action Suit Against Baxter 114
8.2.8 Sep 10, 2010: Celsis IVT Wins Preliminary Injunction Against Life Technologies And CellzDirect In LiverPool Patent Infringement Lawsuit 114
8.2.9 Sep 10, 2010: AG Coakley's Office Recovers $525,000 From Clinical Science To Settle Allegations Of Medicaid Fraud 115
8.2.10 Sep 07, 2010: Precision BioSciences Wins Stay Of Patent Litigation Against Cellectis 116
8.2.11 Sep 03, 2010: Robbins Geller Files Class Action Suit Against Beckman Coulter 116
8.2.12 Jul 13, 2010: Cepheid Files Answer And Counterclaims In Abaxis Patent Suit 117
8.2.13 Jul 08, 2010: Haemonetics Settles German Patent Suit With STRADIS-MED 117
8.2.14 Jul 08, 2010: Haemonetics Settles Pending Legal Action Against Stradis-Med 117
8.2.15 Jul 02, 2010: Levi & Korsinsky Investigates Possible Breach Of Fiduciary Duty By Board Of Abraxis BioSciences 118
8.2.16 Jun 30, 2010: Celsis Seeks Injunction Against Invitrogen For LiverPool Patent Infringement 118
8.2.17 Jun 02, 2010: Appellate Court Decides Against Haemonetics On Patent Case: Fenwal 119
8.3 Government and Public Interest 119
8.3.1 Nov 18, 2010: Inefficiencies At FDA Delay Patient Access, Increase Costs Of New Medical Technologies: AdvaMed 119
8.3.2 Nov 16, 2010: New Test Can Screen All Deafness Genes Simultaneously: University Of Iowa 120
8.3.3 Nov 15, 2010: Study Shows New Blood Test May Help Predict Heart Failure And Cardiovascular Death In Apparently Healthy Older Adults: University of Maryland Study 121
8.3.4 Nov 05, 2010: New Urine Test Could Diagnose Acute Kidney Injury: JASN 122
8.3.5 Oct 27, 2010: 1000 Genomes Project Publishes Analysis Of Completed Pilot Phase: Broad Institute Of MIT And Harvard 123
8.3.6 Oct 26, 2010: CHI Announces New White Paper On 510(k) Reform Initiatives 125
8.3.7 Oct 26, 2010: Prostate Cancer Screening Improves Quality Of Life By Catching Disease Before It Spreads: American Society For Radiation Oncology 126
8.3.8 Oct 19, 2010: New Sensor Derived From Frogs May Help Fight Bacteria And Save Wildlife: Princeton University, Engineering School 126
8.3.9 Oct 15, 2010: Simple Blood Test Helps Predict Chronic Kidney Disease: ASN 128
8.3.10 Oct 13, 2010: Not All Doctors Comply With Practice Guidelines For Recommending Colorectal Cancer Screenings: Study 129
8.3.11 Oct 06, 2010: Blood Test Could Diagnose Alzheimer's Disease: UT Southwestern Researchers 129
8.3.12 Oct 05, 2010: FDA Seeks Comments On Recommended Glossary And Educational Outreach To Support Use Of Symbols On Labels And In Labeling Of In Vitro Diagnostic Devices Intended For Professional Use 130
8.3.13 Oct 05, 2010: Researchers Develops New Methods To Detect Early Lung Cancer Detection: Northwestern University 130
8.3.14 Sep 30, 2010: Intraluminal Protection IV Needleless Connector Eliminates Dangerous Catheter Infections: Methodist Study 132
8.3.15 Sep 29, 2010: MicroRNA Panel Provides More Precise Lung Cancer Diagnosis: American Association For Cancer Research 133
8.3.16 Sep 29, 2010: Screening Tool Can Detect Colorectal Cancer From Small Blood Sample: American Association For Cancer Research 133
8.3.17 Sep 29, 2010: Dual-Capture CTC Chip Efficiently Captures Breast Cancer Cells: American Association For Cancer Research 134
8.3.18 Sep 29, 2010: ARUP Recognized As Sustaining Member Of Utah Safety Council 134
8.3.19 Sep 28, 2010: New Biomarkers Discovered For Pancreatic Cancer And Mesothelioma: American Association For Cancer Research 135
8.4 Product News 136
8.4.1 Nov 24, 2010: Study Confirms Accuracy Of Roche's Human Papillomavirus Test For Detection Of Cervical Pre-Cancer Missed By Existing Screening Methods 136
8.4.2 Nov 22, 2010: OraSure Technologies Receives FDA Approval To Conduct Final Phase Of Clinical Studies For OraQuick OTC HIV Test 136
8.4.3 Nov 19, 2010: Biodesix Reports VeriStrat Test Identifies Lung Cancer Patients Benefiting From Combination Therapy 136
8.4.4 Nov 18, 2010: Ridge Diagnostics Presents Clinical Data On Blood Test For Depression At US Psychiatric And Mental Health Congress 137
8.4.5 Nov 17, 2010: Rheonix Announces Issuance Of New Patent For Its Microfluidic Diagnostic Platform 137
8.4.6 Nov 12, 2010: Abaxis Releases New Piccolo BioChemistry Panel Plus 138
8.4.7 Nov 08, 2010: Clinical Data Launches FAMILION Genetic Tests For Left Ventricular Noncompaction And Long QT Syndrome Large Deletion/Duplication Mutations 139
8.4.8 Nov 08, 2010: Crescendo Bioscience Launches Vectra DA Multi-Biomarker Blood Test For Rheumatoid Arthritis Disease Activity 139
8.4.9 Nov 05, 2010: IntegenX Launches Apollo 324 System For Automated DNA Library Preparation At ASHG Meeting 140
8.4.10 Nov 04, 2010: AspenBio Receives Research Award From Federal Government On AppyScore 140
8.4.11 Nov 03, 2010: Affymetrix To Provide Data Set Of Millions Of Genotypes To 1000 Genomes Project 141
8.4.12 Nov 03, 2010: Idaho Technology Submits FilmArray Respiratory Panel To FDA For 510(k) Clearance 141
8.4.13 Nov 02, 2010: Exact Sciences Receives $244,500 In Federal Grant Funding For Cologuard For Detection Of Colorectal Cancers And Pre-Cancers 142
8.4.14 Nov 02, 2010: Innovotech Testing Contributes To FDA Market Clearance For Teleflex' ArrowEVOLUTION Anti-Microbial Coated Catheter 142
8.4.15 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 142
8.4.16 Oct 28, 2010: Exact Sciences Reports Positive Results For Cologuard Stool-Based Screening Test 143
8.4.17 Oct 27, 2010: AutoGenomics Receives FDA Clearance for its INFINITI CYP2C19 Assay 143
8.4.18 Oct 26, 2010: Life Technologies Establishes New Standard For Single-Read Accuracy In Next Generation Sequencing 144
8.4.19 Oct 26, 2010: Illumina Announces HiSeq 1000 Sequencing System 144
8.4.20 Oct 25, 2010: BD Announces BD Vacutainer Rapid Serum Tube Helps Improve Healthcare Worker Safety, Patient Care And Hospital Productivity 144
8.4.21 Oct 25, 2010: Roche Receives FDA Approval For PCR COBAS TaqMan HCV Test, v2.0 145
8.4.22 Oct 21, 2010: Caliper Introduces DNA Assay For Next Generation Sequencing Workflows 145
8.4.23 Oct 21, 2010: DermaGenoma Launches HairDX Genetic Test For Female Androgen Sensitivity 145
8.4.24 Oct 20, 2010: PinPointe Receives FDA Clearance For PinPointe FootLaser To Treat Nail Fungus 146
8.4.25 Oct 11, 2010: Agilent Launches SurePrint G3 Human CGH+SNP Microarray Platform 146
8.4.26 Oct 11, 2010: Biomagnetics Diagnostics And LANL Reach Major Milestone In Development Of Integrated Optical Biosensor 146
8.4.27 Oct 06, 2010: RBM Announces Commercial Availability Of VeriPsych 147
8.4.28 Oct 06, 2010: RBM Releases VeriPsych Blood-Based Diagnostic Test For Schizophrenia 147
9 Appendix 149
9.1 Definitions of Markets Covered in the Report 150
9.1.1 In Vitro Diagnostics 150
9.2 Research Methodology 152
9.3 Secondary Research 152
9.4 Primary Research 153
9.5 Models 153
9.6 Forecasts 154
9.7 Expert Panels 154
9.8 GlobalData Consulting 154
9.9 Currency Conversion 155
9.10 Contact Us 155
9.11 Disclaimer 1551.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2002-2016 13
Table 2: In Vitro Diagnostics, North America, Overall Revenue ($m), 2002-2016 15
Table 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2002-2016 16
Table 4: In Vitro Diagnostics, North America, Overall Revenue ($m), Historic, 2002-2009 18
Table 5: In Vitro Diagnostics, North America, Overall Revenue ($m), Forecast, 2009-2016 20
Table 6: In Vitro Diagnostics, North America, Company share by Revenue ($m), 2008-2009 22
Table 7: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 24
Table 8: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009 26
Table 9: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016 28
Table 10: Clinical Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009 29
Table 11: Genetic Testing, United States, Distribution Share by Revenue ($m), 2008-2009 29
Table 12: Haematology, United States, Distribution Share by Revenue ($m), 2008-2009 30
Table 13: Histology And Cytology, United States, Distribution Share by Revenue ($m), 2008-2009 30
Table 14: Immuno Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009 31
Table 15: Infectious Immunology, United States, Distribution Szhare by Revenue ($m), 2008-2009 31
Table 16: Microbiology Culture, United States, Distribution Share by Revenue ($m), 2008-2009 32
Table 17: In Vitro Diagnostics, United States, Company Share by Revenue ($m), 2008-2009 34
Table 18: Clinical Chemistry, United States, Company Share by Revenue ($m), 2008-2009 36
Table 19: Genetic Testing, United States, Company Share by Revenue ($m), 2008-2009 38
Table 20: Haematology, United States, Company Share by Revenue ($m), 2008-2009 40
Table 21: Histology And Cytology, United States, Company Share by Revenue ($m), 2008-2009 42
Table 22: Immuno Chemistry, United States, Company Share by Revenue ($m), 2008-2009 44
Table 23: Infectious Immunology, United States, Company Share by Revenue ($m), 2008-2009 46
Table 24: Microbiology Culture, United States, Company Share by Revenue ($m), 2008-2009 48
Table 25: In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016 50
Table 26: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2002-2009 52
Table 27: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2009-2016 54
Table 28: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), 2008-2009 55
Table 29: Genetic Testing, Canada, Distribution Share by Revenue ($m), 2008-2009 55
Table 30: Haematology, Canada, Distribution Share by Revenue ($m), 2008-2009 56
Table 31: Histology And Cytology, Canada, Distribution Share by Revenue ($m), 2008-2009 56
Table 32: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), 2008-2009 57
Table 33: Infectious Immunology, Canada, Distribution Share by Revenue ($m), 2008-2009 57
Table 34: Microbiology Culture, Canada, Distribution Share by Revenue ($m), 2008-2009 58
Table 35: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), 2008-2009 60
Table 36: Clinical Chemistry, Canada, Company Share by Revenue ($m), 2008-2009 62
Table 37: Genetic Testing, Canada, Company Share by Revenue ($m), 2008-2009 64
Table 38: Haematology, Canada, Company Share by Revenue ($m), 2008-2009 65
Table 39: Histology And Cytology, Canada, Company Share by Revenue ($m), 2008-2009 67
Table 40: Immuno Chemistry, Canada, Company Share by Revenue ($m), 2008-2009 69
Table 41: Infectious Immunology, Canada, Company Share by Revenue ($m), 2008-2009 71
Table 42: Microbiology Culture, Canada, Company Share by Revenue ($m), 2008-2009 72
Table 43: Renato To Merge With Pharmaceutical Group And Medical Clinics 83
Table 44: Genelex Merges With Mental Health Connections 84
Table 45: ChromoCure Merges With Genome Research Group 85
Table 46: Geonostics Acquires FlexSite Diagnostics 86
Table 47: ITT Completes The Acquisition Of O.I. 87
Table 48: Med BioGene Announces The Sale Of The Company 88
Table 49: GE Healthcare Receives US Antitrust Approval To Acquire Clarient 89
Table 50: Pole Perfect Studios To Acquire LumiGene Technologies In Reverse Acquisition 91
Table 51: ERBA DIAGNOSTICS MANNHEIM Completes Acquisition Of 72% Stake In IVAX Diagnostics From Patrice Debregeas and Paul Kennedy 92
Table 52: NEC Invests $5 Million In SomaLogic 93
Table 53: Ventana Medical Systems To Acquire BioImagene 94
Table 54: Vermillion Enters Into An Agreement With Quest Diagnostics 95
Table 55: Radient Pharmaceuticals Enters Into An Agreement With Provista Diagnostics 96
Table 56: Cepheid Enters Into Collaboration With Novartis 97
Table 57: T-Ray Science Enters Into Research Agreement With The BC Cancer Agency 98
Table 58: BD Diagnostic Enters Into An Agreement With Bruker Daltonics 99
Table 59: ECI Biotech Enters Into An Agreement With Systagenix Wound Management 100
Table 60: Celera Enters Into Distribution Agreement With Abbott Laboratories 101
Table 61: Prometheus Laboratories Enters Into Research Collaboration And License Agreement With Tarrot Laboratories 102
Table 62: Biomoda Signs Research Agreement With Saccomanno Research Institute 103
Table 63: USD to Local Currency, North America, Average Exchange Rate 2002-2009 1551.2
List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2002-2016 13
Figure 2: In Vitro Diagnostics, North America, Overall Revenue ($m), 2002-2016 14
Figure 3: In Vitro Diagnostics, North America, Cross-Category Analysis, 2002-2016 16
Figure 4: In Vitro Diagnostics, North America, Overall Revenue ($m), Historic, 2002-2009 17
Figure 5: In Vitro Diagnostics, North America, Overall Revenue ($m), Forecast, 2009-2016 19
Figure 6: In Vitro Diagnostics, North America, Company share (%), 2009 21
Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 23
Figure 8: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009 25
Figure 9: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016 27
Figure 10: In Vitro Diagnostics, United States, Company Share (%), 2009 33
Figure 11: Clinical Chemistry, United States, Company Share (%), 2009 35
Figure 12: Genetic Testing, United States, Company Share (%), 2009 37
Figure 13: Haematology, United States, Company Share (%), 2009 39
Figure 14: Histology And Cytology, United States, Company Share (%), 2009 41
Figure 15: Immuno Chemistry, United States, Company Share (%), 2009 43
Figure 16: Infectious Immunology, United States, Company Share (%), 2009 45
Figure 17: Microbiology Culture, United States, Company Share (%), 2009 47
Figure 18: In Vitro Diagnostics, Canada, Overall Revenue ($m), 2002-2016 49
Figure 19: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2002-2009 51
Figure 20: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2009-2016 53
Figure 21: In Vitro Diagnostics, Canada, Company Share (%), 2009 59
Figure 22: Clinical Chemistry, Canada, Company Share (%), 2009 61
Figure 23: Genetic Testing, Canada, Company Share (%), 2009 63
Figure 24: Haematology, Canada, Company Share (%), 2009 65
Figure 25: Histology And Cytology, Canada, Company Share (%), 2009 66
Figure 26: Immuno Chemistry, Canada, Company Share (%), 2009 68
Figure 27: Infectious Immunology, Canada, Company Share (%), 2009 70
Figure 28: Microbiology Culture, Canada, Company Share (%), 2009 72
Figure 29: Siemens Healthcare, Company Share (%), North America In Vitro Diagnostics Market, 2009 73
Figure 30: Abbott Laboratories, Company Share (%), North America In Vitro Diagnostics Market, 2009 74
Figure 31: F. Hoffmann-La Roche Ltd., Company Share (%), North America In Vitro Diagnostics Market, 2009 75
Figure 32: Beckman Coulter, Inc., Company Share (%), North America In Vitro Diagnostics Market, 2009 76
Figure 33: Ortho-Clinical Diagnostics Inc., Company Share (%), North America In Vitro Diagnostics Market, 2009 77
Figure 34: Alere Inc, Company Share (%), North America In Vitro Diagnostics Market, 2009 78
Companies mentioned
Siemens Healthcare
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Alere Inc
Becton, Dickinson and Company
bioMerieux S.A.
Qiagen N.V.
Bio-Rad Laboratories, Inc.
Gen-Probe Incorporated
Hologic, Inc.
Sysmex Corporation
Phadia AB
To order this report:
In Vitro Diagnostic Industry: North America In Vitro Diagnostics Market Outlook to 2016
In Vitro Diagnostic Business News
Check our Company Profile, SWOT and Revenue Analysis!
Contact: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article